Therapeutics

With $65M, Cygnal Tunes In to Nerve Signals for Drug-Making Clues

7 monthes ago   |   By Xconomy

The peripheral nervous system traverses the body, connecting the brain and spinal cord to distant organs and limbs similar to the way a fiber optic network connects an Internet provider to a computer user at a far-flung home. But peripheral nerves also communicate with disease cells, according to Cygnal Therapeutics CEO Pearl Huang. Understanding this dialogue is key to unlocking a new approach to treating disease, she says. Cambridge, MA-based Cygnal has spent the past two years studying the peripheral nervous system and its back-and-forth communication with disease cells. Today, the...
Read more ...

 


Search by Tags

   Therapeutics      BioTech      Fibers      Brain      Biotech      Computers      Drug      Drugs      Boston      Boston blog main      Boston top stories      National blog main      Autoimmune Diseases      Central Nervous System      Cygnal Therapeutics      Drug discovery      Fibrosis      Flagship Pioneering      Life Sciences      Metabolism      Pearl Huang      Peripheral Nervous System      Regenerative Medicine      Startups  


World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

Forma Therapeutics Eyes IPO to Advance Sickle Cell, Prostate Cancer Drugs

Forma Therapeutics Eyes IPO to Advance Sickle Cell, Prostate Cancer Drugs

Forma Therapeutics has developed a pipeline of small molecules aimed at rare blood disorders and cancers, but it aims to advance two-investigational treatments for sickle cell... Read more ...

Bio Roundup: ASCO Opens, Merck Takes On COVID, Evofem's Approval & More

Bio Roundup: ASCO Opens, Merck Takes On COVID, Evofem's Approval & More

A year ago about 40,000 people gathered in Chicago for the annual meeting of the American Society of Clinical Oncology. Today a virtual version of the ASCO conference, the... Read more ...

AbbVie Wins First FDA Approval of Drug to Treat Uterine Fibroid Bleeds

AbbVie Wins First FDA Approval of Drug to Treat Uterine Fibroid Bleeds

An AbbVie drug that treats pain in the uterus has notched an additional FDA approval for addressing heavy menstrual bleeding associated with uterine fibroids. The regulatory... Read more ...

Daya Bay Reactor Experiment Continues to Generate Data

Daya Bay Reactor Experiment Continues to Generate Data

Antineutrino detectors are submersed in liquid at the Daya Bay experiment, as seen during the final phase of construction in August 2012. Experiment: Daya Bay reactor neutrino... Read more ...

Seeing Cancer, But Not Through a Microscope

Seeing Cancer, But Not Through a Microscope

Toward the end of the 19th century, a French doctor named Ernest Besnier coined the term “ biopsy ,” combining the Greek bios and opsis. In the decades since, clinicians have... Read more ...

Variant Emerges With $16M to Find “Outlier Humans” to Reveal New Drugs

Variant Emerges With $16M to Find “Outlier Humans” to Reveal New Drugs

Human DNA holds secrets that, once uncovered, have led scientists to develop a number of treatments for disease. A slew of biopharmas and biotechs-not to mention national... Read more ...

Don't Wait for “Them” to Find Your Weaknesses

Don't Wait for “Them” to Find Your Weaknesses

Our Professional Services Written by: Crystal Booth, M.M.- Regional Manager, Southeast USA at PSC Biotech We've probably all heard the phrase “audit ready state”. But what does... Read more ...

Functional oral nanoparticles for delivering silibinin and cryptotanshinone...

Breast cancer lung metastasis occurs in more than 60% of all patients with breast cancer, and most of those afflicted by it eventually die of recurrence. The tumor... Read more ...

Escherichia coli metabolism under short-term repetitive substrate dynamics...

Microbial metabolism is highly dependent on the environmental conditions. Especially, the substrate concentration, as well as oxygen availability, determine the metabolic... Read more ...

High-yield production of l-serine through a novel identified exporter...

L-Serine has wide and increasing applications in industries with fast-growing market demand. Although strategies for achieving and improving l-serine production in... Read more ...